A novel gene variation of TNFα associated with ankylosing spondylitis: A reconfirmed study

Annals of the Rheumatic Diseases

Volumn 66, Issue 11, 2007, Pages 1419-1422

  Zhu, Xiaoquan ^a,b   Wang, Yawen ^c,e   Sun, Liang ^a,d   Song, Yuguo ^c   Sun, Fei ^a   Tang, Lei ^a   Huo, Zhenghao ^f   Li, Jianxin ^e   Yang, Ze ^a  

^a BEIJING HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c BEIHUA UNIVERSITY   (China)

^d INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

^e Key Laboratory of Reproductive Health   (China)

^f NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; CHROMOSOME; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-B27 ANTIGEN; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35649019869     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.068528     Document Type: Article

References (17)

1. Davis JC Jr, Van Der Heijde D, Braun J, Dougados M, et al. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 2003;48:3230-6.
2. Anderson JJ, Baron G, Van Der Heijde D, Felson DT, Dougados M. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 2001;44:1876-86.
3. Braun J, Pham T, Sieper J, Davis J, van der Linden SJ, Dougados JM, et al. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 2003;62:817-24.
4. Zhu XQ, Zeng QY, Sun L, Wang G, Tang L, Hou ZD, et al. Recognition and study of susceptible gene to ankylosing spondylitis. Hereditas 2005;27:1-6.
5. van der Linden SM, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
6. Okamoto K, Makino S, Yoshikawa Y, Takaki A, Nagatsuka Y, Ota M, et al. Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. Am J Hum Genet 2003;72:303-12.
7. Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T, et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002;32:650-4.
8. Steffens-Nakken HM, Zwart G, van den Bergh FAJTM. Validation of allele-specific polymerase chain reaction for DNA typing of HLA-B27. Clin Chem 1995;41:687-92.
9. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
10. Prkins ND, Schmid RM, Duckett CS, Leung K, Rice NR, Nabel GJ. Distinct combinations of NF-κB subunits determine the specificity of transcriptional activation. Proc Natl Acad Sci U S A 1992;89:1529- 33.
11. Schmitz ML, Baeuerle PA. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J 1991;10:3805-17.
12. Udalova IA, Richardson A, Denys A, Smith S, Ackerman H, et al. Functional consequences of a polymorphism affecting NF-κ p50-p50 binding to the TNF promoter region. Mol Cell Biol 2000;20:9113-19.
13. Weston K. Extension of the DNA binding consensus of the chicken c-Myb and v-Myb proteins. Nucleic Acids Res 1992;20:3043-49.
14. Calin A, Marder A, Becks E, Burns T. Genetic differences between B27 positive patients with ankylosing spondylitis and B27 positive healthy controls. Arthritis Rheum 1983;26:1460-4.
15. Laval SH, Timms A, Edwards S, Bradbury L, Brophy S, Milicic A, et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 2001;68:918- 26.
16. Chou CT, Timms AE, Wei JC, Tsai WC, Wordsworth BP, Brown MA. Replication of association of IL1 gene complex members with ankylosing spondylitis in Taiwanese Chinese. Ann Rheum Dis 2006;65:1106-9.
17. Timms AE, Crane AM, Sims AM, Cordell HJ, Bradbury LA, Abbott A, et al. Related Articles, Links The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. Am J Hum Genet 2004;75:587-95.